Algo version: 0.98b
Aurisco Pharmaceutical is listed at the SHH Exchange
Aurisco Pharmaceutical [605116.SS]
SHH Sector: Healthcare Industry:Biotechnology

Is Aurisco Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Aurisco Pharmaceutical pays dividends. Last time was Thursday 6th of June 2024 where the investors holding the stock on Thursday 6th of June 2024 were paid CNY0.22 per share. Over the last 4 times between 2021 and 2024, Aurisco Pharmaceutical has paid CNY0.63 with an average of CNY0.16 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Aurisco Pharmaceutical 10 years ago, but if you had invested on Monday 21st of September 2020 when the price was CNY12.05, you would have made a profit of CNY10.60 per share or 87.97%

Yes, the average daily trading liquidity for Aurisco Pharmaceutical is CNY2.45 million. You should therefore be able to get in and out of your positions relatively fast.

Aurisco Pharmaceutical has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 2.55, the company's ability to pay off the debt is good. Aurisco Pharmaceutical has a very good net profit margin of 25.13% and should have very high tolerances against inflation.

We have calculated the inflation risk for Aurisco Pharmaceutical to be low [0 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.